Hot Articles

Blue Apron Holdings Inc (APRN) Stock Rose 19% In A Week, Is It Time To Watch The Stock?

Blue Apron Holdings Inc (APRN) stock had a 19% rise in a recent week. But YTD, shares of APRN stock have shed around 28% of value. Does the rise at this moment mean that it is time to buy the stock?
Jack Austen - 5 hours ago

Is PAVmed (PAVM) Stock Worth Buying After It Got Rid Of Penny Stock Levels?

PAVmed (NASDAQ: PAVM) stock has gone from penny stock levels to trading well above $5 a share. This medical technology company's stock has already reached a 203% rise so far this year. So, is it time to buy this stock now?
Amsden Lindsay - 18 hours ago

Is Allied Healthcare Products (AHPI) Stock Worth Buying After It Had A 39% Rise In A Day?

Allied Healthcare Products (NASDAQ: AHPI) stock had a 39% rise in heavy trading on Friday. However, there is no reason behind this growth as of yet. It appears to be another short squeeze game by retail investors. Anyway, AHPI stock is currently in an uptrend momentum, should you buy it now?
Jack Austen - July 31, 2021

GT Biopharma (GTBP) Stock Fell 27% In A Month, Is This Stock Worth Buying Now?

GT Biopharma (NASDAQ: GTBP) stock fell by 27% in the past month. This clinical stage immuno-oncology company has three product candidates in its clinical pipeline, which are all in the early phases of study. So, is this stock worth buying now?
Amsden Lindsay - July 30, 2021

Is Teva Pharmaceutical (TEVA) Stock Worth Buying After Announcing An Increase of 1% In Its Revenue?

Teva Pharmaceutical (NYSE: TEVA) stock was up by 12% on Wednesday. A week ago, the stock hit a new low this year, but now, this stock seems to have ended its downtrend. So, is it time to buy the stock now?
Amsden Lindsay - July 29, 2021

Naked Brand (NAKD) Stock Has Been Running At Low Levels Over The Past Few Months, Is This Stock Worth Buying?

Naked Brand (NASDAQ: NAKD) stock has continued to run at low levels over the past few months. Despite NAKD is a meme stock which were favored by retail investors, it can not help.
Jack Austen - July 28, 2021

Is Bit Digital Inc (BTBT) Stock Worth Buying After Having A 110% Increase In A Day?

Bit Digital Inc (NASDAQ: BTBT) stock had a 110% increase on Monday. At the same time, the price of Bitcoin also hit a new six-week high. One of the reasons for Bitcoin's rise is due to the rumor that Amazon may start accepting the cryptocurrency at the end of this year. So, is BTBT stock worth buying now?
Amsden Lindsay - July 27, 2021

IZEA Worldwide (IZEA) Stock Fell 16% In A Month, Is This Stock Still Worth Buying?

Shares of IZEA Worldwide (NASDAQ: IZEA) fell by 16% over the past month. In fact, the stock has continued to fall In the past six months. Last Friday, the company released a positive news, which did not push its stock to rise significantly. So, is this stock still worth buying?
Amsden Lindsay - July 26, 2021

Is 9 Meters Biopharma (NMTR) Stock Worth Buying?

9 Meters Biopharma (NASDAQ: NMTR) stock has been running at low levels over the past four months. Recently, the company announced that it has acquired global development rights to a proprietary and highly specific humanized monoclonal antibody, then, its stock price increased slightly. So, is the stock worth buying now?
Jack Austen - July 25, 2021

Acasti Pharma Inc (ACST) Stock Fell 22% In A month, Is The Stock Still Worth Buying?

Acasti Pharma Inc (NASDAQ: ACST) stock dropped by 22% in the past month. For investors, the company's future does not seem to be very clear, perhaps, it is not a good time to buy the stock now.
Amsden Lindsay - July 24, 2021

Is Xenetic Biosciences (XBIO) Stock Worth Buying After Having A 35% Increase?

On Friday, Xenetic Biosciences (NASDAQ: XBIO) stock had a 35% increase. However, the reason for the rise of this stock might not be the result of short squeeze by retail investors. Rather, the company is benefitting from its partner, Takeda Pharmaceuticals Co. Ltd.
Jack Austen - July 24, 2021

BIOLASE (BIOL) Stock Fell 22% In A Month, Is The Stock Still Worth Buying?

BIOLASE Inc (NASDAQ: BIOL) stock fell 22% in the past month. In fact, the stock has been running below $1 for the past four months, and it is now at $0.59 per share, so, is the stock still worth buying?
Amsden Lindsay - July 23, 2021

Is Clovis Oncology (CLVS) Stock That Is Always Running At Low Levels Worth Buying?

Clovis Oncology (NASDAQ: CLVS) stock reached the highest point this year in February, and then has been running at low levels. The company will release its second quarter 2021 financial results on August 4, 2021, should you buy it now?
Jack Austen - July 22, 2021

Is Ozop Energy Solutions (OZSC) Stock A Buy After Having a 23% Increase?

Ozop Energy Solutions (OTCMKTS: OZSC) stock had a 23% increase on Tuesday. However, the company has not released any news recently, and its trading volume has not been significantly enlarged, so, is the stock worth buying now?
Amsden Lindsay - July 21, 2021

Is It Time To Buy Northwest Biotherapeutics (NWBO) Stock?

On Monday, Northwest Biotherapeutics (OTCMKTS: NWBO) had an 8.59% increase, creating the largest rise in the past two months. The company has not yet released the top-line data of its phase III trial of DCVax®-L, so, should investors buy the stock now?
Amsden Lindsay - July 20, 2021

Clean Energy Fuels Corp (CLNE) Stock Fell 33% In A Month, Is The Stock Still Worth Buying Now?

Clean Energy Fuels Corp (NASDAQ: CLNE) stock had lost 33% over the past month, and it is now at $7.56 per share. The stock currently does not seem to be very attractive to investors, perhaps considering its excessive market value.
Amsden Lindsay - July 19, 2021

Verb Technology (VERB) Stock Surged 141% In A Month, Should You Buy It Now?

Verb Technology Company (NASDAQ: VERB) stock was up by 141% in the past month. The company recently released two hot news, which directly pushed its stock price to new high this year. So, should you buy it now?
Jack Austen - July 18, 2021

Aerpio Pharmaceuticals (ARPO) Stock Appears To Get Solid Bullish Momentum Right Now, Should You Buy It?

Aerpio Pharmaceuticals (NASDAQ: ARPO) stock appears to be witnessing solid bullish momentum right now. Now ARPO stock price is at $2.06 per share, will the stock hit the $2.5 level again in a short period of time?
Amsden Lindsay - July 17, 2021

Is ConforMIS (CFMS) Stock Worth Buying?

ConforMIS (NASDAQ: CFMS) stock has seen a rising trend in the past few days. The stock has challenged $1.4 three times this year, and it is now $1.13 per share, so, should you buy it now?
Amsden Lindsay - July 17, 2021

Is Cinedigm (CIDM) Stock Worth Buying After Declaring Zero Debt?

Cinedigm (NASDAQ: CIDM) stock surged 38% at the close of the market on Thursday. The reason investors were so excited is that the company announced that it has reduced its debt balance to zero from almost $49 Million at the end of the last fiscal year. Cinedigm said that its strong debt-free balance sheet will support its rapidly growing streaming business and accretive acquisition.
Jack Austen - July 16, 2021

Zomedica Corp (ZOM) Stock Is Still Worth Watching Although It Went Down Recently

Zomedica Corp (NYSEAMERICAN: ZOM) stock went down 31% in the past month, but it still had an 80% increase this year. TRUFORMA is the company's flagship product, but its revenue for the next quarter is still unpredictable. Perhaps it is not a time to make any decisions about this stock.
Jack Austen - July 15, 2021

Is American Battery Metals Corporation (ABML) Stock Worth Buying After Its Plant Is Approved?

American Battery Metals Corporation (OTCMKTS: ABML) stock has continued to fluctuate between $1 and $3 in the past four months. On July 8, the company confirmed that its mass grading permit for its Lithium-Ion Battery Recycling Pilot Plant was approved by the City of Fernley, Nevada, and then, its stock price had a small increase.
Jack Austen - July 14, 2021

Gevo (GEVO) Stock Is Down 20% In A Month, Is There A Buying Opportunity Now?

Gevo (NASDAQ: GEVO) stock was down by 20% in the past month. The $10 seems to be its resistance level, and it is now $6.65 per share. So, is there a buying opportunity for the stock now?
Jack Austen - July 13, 2021

Ashford Hospitality Trust (AHT) Stock Had A Reverse Split Of Its Common Shares, Is The Stock Worth Buying?

Ashford Hospitality Trust (NYSE: AHT) stock reached its highest point since the year last month, and then, it had a sharp drop. On July 2, the company announced that a reverse split of its common stock at a ratio of 1-for-10, so, is the stock worth buying now?
Amsden Lindsay - July 11, 2021

Toughbuilt Industries (TBLT) Stock Surged 46% On The Last Trading Day Of Week, Is The Stock Worth Buying?

Toughbuilt Industries (NASDAQ: TBLT) stock surged by 46% on Friday. The company released a positive news on Thursday, which directly pushed its stock price up. So, is the stock worth buying now?
Jack Austen - July 10, 2021

Exela Technologies (XELA) Stock Surged 72% In A Month, Is It Time To Buy This Stock?

Exela Technologies (NASDAQ: XELA) stock surged 72% in the past month. The company recently released a series of good news, which caused its stock price to rise sharply. So now, is it time to buy this stock?
Jack Austen - July 10, 2021

LM Funding America (LMFA) Stock Just Experienced A Roller Coaster Ride In Price, Is It Worth Buying Now?

LM Funding America (NASDAQ: LMFA) stock just experienced a roller coaster ride in price this week. The stock broke through the $12 per share in early this year, and now, it only has $5. So, is this stock worth buying now?
InvestReader Editor - July 09, 2021

Corbus Pharmaceuticals (CRBP) Stock Fell 24% In A Month, Is This Stock Still Worth Buying?

Corbus Pharmaceuticals (NASDAQ: CRBP) stock fell 24% in the past month. Corbus announced last month that the results from its Phase 3 study of Lenabasum did not meet primary endpoint of total improvement score at Week 28, which accelerated its stock price decline.
InvestReader Editor - July 08, 2021

ENGlobal Corp (ENG) Stock Continues To Run At A Low Level, Is This Stock Worth Buying?

ENGlobal Corp (NASDAQ: ENG) stock has continued to run at a low level in the past two months. Although the stock broke through the $8 in February this year, it is only $2.91 per share now. So, is this stock worth buying now?
InvestReader Editor - July 07, 2021

Professional Diversity Network (IPDN) Stock Has Risen 35% This Month, Is This Stock Worth Buying?

Professional Diversity Network (NASDAQ: IPDN) stock has risen by 35% so far this month. Despite there was no positive news from the company recently, the stock has the reasons to catch the eyes of investors.
InvestReader Editor - July 06, 2021